deferiprone Oral Solution
- Brand(s)
- Ferriprox
- Category(s)
- prescription
- SPL Type(s)
- Human Prescription
- Master SPL
- Apo-Pharma Usa, Inc (2015-09-15)
- Oldest Current Product
- 2015-09-09
- License(s)
- NDA
- RxNORM
- ORAL SOLUTION\DEFERIPRONE
- FDAOB
- ORAL\SOLUTION\DEFERIPRONE
- SPL Active
- ORAL\SOLUTION\DEFERIPRONE
- SPL Moiety
- ORAL\SOLUTION\DEFERIPRONE
product(s) by strength(s)
deferiprone 100 mg/ml oral solution
# | id | title | applicant | approved | patent | exclusivity | approved drug |
---|
1 | NDA208030 | FERRIPROX | APOPHARMA INC | 2015-09-09 | p8703156, METHOD OF TREATING CHRONIC IRON OVERLOAD, SUBSTANCE p7049328, METHOD OF TREATING CHRONIC IRON OVERLOAD | NEW CHEMICAL ENTITY [2016-10-14] ORPHAN DRUG EXCLUSIVITY [2016-10-14] | NDA208030_001 |
# | id | category/deprecated | ingredient strength(s) | route | dose form | rld | approved | application |
---|
1 | NDA208030_001 | RX | DEFERIPRONE (100MG/ML) | ORAL | SOLUTION | True | 2015-09-09 | FERRIPROX |
# | id | title | category | type | labeler | labeler act | last update | version | product(s) |
---|
1 | 97f7bfcb-8666-464c-87b6-9621ceca5ee2 (view SPL) | These highlights do not include all the information needed to use FERRIPROX safely and effectively. See full prescribing information for FERRIPROX. FERRIPROX (deferiprone) oral solution, for oral useInitial U.S. Approval: 2011 | prescription | Human Prescription | Apo-Pharma Usa, Inc | analysis, manufacture | 2015-09-15 | 9 | 526094502 |